Growth Metrics

Gilead Sciences (GILD) Current Assets (2016 - 2026)

Gilead Sciences filings provide 17 years of Current Assets readings, the most recent being $18.3 billion for Q4 2025.

  • On a quarterly basis, Current Assets fell 4.33% to $18.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $18.3 billion, a 4.33% decrease, with the full-year FY2025 number at $18.3 billion, down 4.33% from a year prior.
  • Current Assets hit $18.3 billion in Q4 2025 for Gilead Sciences, up from $17.9 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $19.2 billion in Q4 2024 to a low of $12.3 billion in Q2 2024.
  • Median Current Assets over the past 5 years was $14.4 billion (2022), compared with a mean of $14.9 billion.
  • Biggest five-year swings in Current Assets: plummeted 54.76% in 2021 and later rose 20.94% in 2025.
  • Gilead Sciences' Current Assets stood at $14.8 billion in 2021, then dropped by 2.23% to $14.4 billion in 2022, then increased by 11.37% to $16.1 billion in 2023, then rose by 19.2% to $19.2 billion in 2024, then dropped by 4.33% to $18.3 billion in 2025.
  • The last three reported values for Current Assets were $18.3 billion (Q4 2025), $17.9 billion (Q3 2025), and $14.7 billion (Q2 2025) per Business Quant data.